Concept paper sul Progetto inibitori di PCSK9: accesso e sostenibilità. SPS: i Supplementi di Polirica Sanitaria; 2019. Zafrir B, Jubran A. Lipid-lowering therapy with PCSK9 inhibitors in the real-world setting: two-year experience of a regional lipid clinic. Cardiovasc Ther. 2018;36(5)...